Audiological outcomes of the Cochlear Osia 2 bone conduction system implanted under expanded indications in a pediatric population
The Osia 2 Bone Conduction System provides significant improvements in audiological outcomes in children ages 5-11 years. Data from this trial led to FDA cleared age expansion in April 2024.
Authors
- Stephanie Berry (ORCID: https://orcid.org/0000-0002-5698-5334)
- Shawn M. Stevens (ORCID: https://orcid.org/0000-0002-7284-1584)
- Catherine Moyer
- Melissa Tribble
- Viral D. Tejani (ORCID: https://orcid.org/0000-0001-7585-9619)
- Gail S. Murray
- Laurie Mauro
- Rebecca Maher
- L M Hill
- Megan Bartoshuk
- Jennifer Drob
- Amanda M Marchegiani
- Marine Cismas
- Julie Purdy
- Elliot Levy
- Abby Meyer
- Jessica L. S. Novak
- Nancy Flores
- Hannah Litton
- Page Aubuchon
- Shannon Doolittle
Institutions
- Barrow Neurological Institute (US)
- Children’s Minnesota - St. Paul Hospital (US)
- Lucile Packard Children's Hospital (US)
- Children's Hospital of Philadelphia (US)
- University Hospitals of Cleveland (US)
- Rady Children's Hospital-San Diego (US)
- North American Skull Base Society (US)
- University Hospitals Cleveland Medical Center (US)
- Children's Minnesota (US)
- Texas Children's Hospital (US)
- Case Western Reserve University (US)
Publication Details
- Journal
- International Journal of Audiology
- Published
- 2025-09-04
- DOI
- https://doi.org/10.1080/14992027.2025.2550530
- Primary Topic
- Hearing Loss and Rehabilitation
- Type
- article
- Field-Weighted Citation Impact
- 0.00